27 April 2017 | News
Transasia Bio-Medicals Ltd. has recently acquired Calbiotech Group of Companies in the US through its German subsidiary Erba Mannheim.
Strengthening its foray into immunoassay, Transasia Bio-Medicals Ltd., India’s leading in-vitro diagnostic company, has recently acquired Calbiotech Group of Companies in the US through its German subsidiary Erba Mannheim.
With this new addition, the Transasia-Erba Group is all set to strengthen its foray in ELISA and CLIA assays for human and animal research, including specific assays for autoimmune disorders, cancer and infectious diseases.
The California-based Calbiotech Group is a global leader in immunoassay development and manufacturing. Whereas, Transasia Bio-Medicals Ltd offers a comprehensive product portfolio spanning all specialties of diagnostics including biochemistry, hematology, immunoassay and blood banking, urinalysis, diabetes, critical care, coagulation, microbiology and molecular diagnostics.
Along with its subsidiaries in Germany, France, Czech Republic, Russia, Turkey, the UK and USA, Transasia now reaches out to millions in over 104 countries.